Clinical Trial Update: The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the effect of sacubitril/valsartan on heart function in chronic hemodialysis patients with heart failure with preserved e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: University Clinical Hospital Mostar | Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF), Hemodialysis | Phase 4 | Status: NOT_YET_RECRUITING